Research Project
Grant-in-Aid for Young Scientists (B)
In the present study, we examined the effects of FR901228, a histone deacetylase (HDAC) inhibitor, on epigenetic regulation of gene expression in oral cancer cell lines. The epigenetic status was quantified before and after FR901228 treatment via chromatin immuno-precipitation assay (ChIP). The methylation status was also quantitatively examined after 5-aza-dC/ FR901228 treatment. Moreover, the alterd-expression of genes related to angiogenesis and invasion may contribute to the recuperation of biological functions linked to FR901228 such as an inhibitory effect on tumor angiogenesis and cell invasion. These results indicate that FR901228 and its target genes may be excellent leads for future studies on the potential benefits of HDAC inhibitors and epigenetics in cancer therapy.
All 2009 2008
All Journal Article (4 results) (of which Peer Reviewed: 4 results) Presentation (3 results) Book (2 results)
Int J Oncol ol.35、No.4
Pages: 893-900
Oncol Rep Vol.22、No.3
Pages: 641-648
Int J Oncol. 35(4)
Pages: 893900-893900
Oncol Rep. 22(3)
Pages: 641648-641648